Up-regulation of Vascular Endothelial Growth Factor C in Breast Cancer Cells by Heregulin-β1
Open Access
- 1 February 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (8) , 5750-5759
- https://doi.org/10.1074/jbc.m204863200
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Microphthalmia Transcription Factor Is a Target of the p38 MAPK Pathway in Response to Receptor Activator of NF-κB Ligand SignalingJournal of Biological Chemistry, 2002
- Phosphatidylinositol 3-Kinase and NF-κB Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen ActivatorJournal of Biological Chemistry, 2002
- p38-dependent marking of inflammatory genes for increased NF-κB recruitmentNature Immunology, 2001
- Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38Journal of Biological Chemistry, 2001
- Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-κB/Rel− specific decoy oligodeoxynucleotidesGene Therapy, 2000
- Serine phosphorylation of paxillin by heregulin-β1: role of p38 mitogen activated protein kinaseOncogene, 1999
- NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathwaysOncogene, 1999
- The oncogene heregulin induces apoptosis in breast epithelial cells and tumorsOncogene, 1998
- Regulation of heregulinβ1-induced differentiation in a human breast carcinoma cell line by the extracellular-regulated kinase (ERK) pathwayJournal of Cellular Biochemistry, 1998
- The significance ofheregulin in breast cancer tumor progression and drug resistanceBreast Cancer Research and Treatment, 1996